Management of Chronic Lung Disease with Drop in SpO2

Immediate Oxygen Delivery Strategy

For patients with chronic lung disease and a drop in oxygen saturation, the American Thoracic Society recommends immediately initiating supplemental oxygen therapy targeting SpO2 88-92% if the patient has risk factors for hypercapnic respiratory failure, or target 94-98% if no such risk factors exist, while simultaneously assessing for acute exacerbation triggers and checking arterial blood gases within 60 minutes 1, 2
For severe hypoxemia (SpO2 <85%), start with a reservoir mask at 15 L/min oxygen flow immediately for life-threatening hypoxemia, and once stabilized, titrate down using nasal cannulae at 1-6 L/min or simple face mask at 5-10 L/min to maintain target saturation 2
For moderate hypoxemia (SpO2 85-93%), if the patient has COPD, cystic fibrosis, neuromuscular disease, chest wall deformities, or morbid obesity, start with 24% Venturi mask at 2-3 L/min or 28% Venturi mask at 4 L/min, targeting SpO2 88-92% 1, 2
For patients without risk factors for CO2 retention, use nasal cannulae at 2-6 L/min or simple face mask at 5-10 L/min, targeting SpO2 94-98% 2, 3
Check arterial blood gases within 60 minutes of starting oxygen to assess for hypercapnia 1, 2

Record respiratory rate, as values >30 breaths/min require immediate escalation even with adequate SpO2 3
Obtain 12-lead ECG urgently to exclude acute coronary syndrome or arrhythmia, as tachycardia with breathlessness may indicate life-threatening cardiopulmonary emergency 3
Measure heart rate, blood pressure, and mental status as these are more sensitive indicators of physiologic distress than oxygen saturation alone 3
Recheck blood gases within 60 minutes if pH falls secondary to rising PaCO2 1

For Chronic Lung Disease of Infancy (CLDI/BPD), target SpO2 90-95% to prevent pulmonary hypertension while avoiding suppression of hypoxic respiratory drive in CO2 retainers 4, 5
For cystic fibrosis with chronic hypoxemia, prescribe home oxygen therapy for severe chronic hypoxemia, with a target SpO2 88-92% due to risk of hypercapnic respiratory failure 6, 2
For COPD exacerbation, do not exceed FiO2 28% via Venturi mask or 2 L/min via nasal cannulae until arterial blood gases are known in patients with COPD history aged ≥50 years 1
Drive nebulizers with compressed air (not oxygen) if PaCO2 elevated or respiratory acidosis present, and continue oxygen at 1-2 L/min via nasal prongs during nebulization to prevent desaturation 1

Using oxygen-driven nebulizers in hypercapnic patients worsens CO2 retention 1
pH <7.26 predicts poor outcome and requires consideration of non-invasive ventilation 1
Persistent hypoxemia despite oxygen therapy, especially with respiratory rate >30/min, requires urgent clinical reassessment 3
Increasing oxygen requirements warrant urgent clinical reassessment 7, 2

The American Thoracic Society recommends promoting lung growth and repair in developing lungs, providing adequate exercise tolerance, diminishing pulmonary artery hypertension and right ventricular workload, and reducing frequency of central apnea and transient pulmonary artery pressure elevations as goals of long-term oxygen therapy 4, 5